A 6-week Randomized, Double-blind, Placebo-controlled, Comparator Referenced, MulticenterTrial of Vabicaserin in Subjects with Acute Exacerbation of Schizophrenia

(Shen J, Zhao Y, Rosenzweig-Lipson S, Popp D, Williams JBW, Giller E, Detke MJ, Kane J)
American College of Neuropsychopharmacology 50th Annual Meeting, Waikoloa Beach HI (December 2011)

Download Poster